CLINICAL_TRIALS
trial_result
· 2010-01-22
Clinical Trial Update: Ramipril 10 mg/Day Prevention [Phase 4]
Summary
Phase 4 trial evaluating Ramipril 10 mg daily for prevention in atherosclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Atherosclerosis | Phase 4 | Status: COMPLETED